Vimab Group AB (OSTO:VIMAB) Margin of Safety % (DCF FCF Based): N/A (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:VIMAB Vimab Group AB OSTO:VIMAB
51 GF Score
Price kr2.97
GF Value kr6.01
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Vimab Group AB Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Vimab Group AB's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.


OSTO:VIMAB vs VRSK, EFX, BAH: Margin of Safety % (DCF FCF Based) Comparison

For the Consulting Services subindustry, Vimab Group AB's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vimab Group AB Margin of Safety % (DCF FCF Based) vs Business Services Industry

For the Business Services industry and Industrials sector, Vimab Group AB's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Vimab Group AB's Margin of Safety % (DCF FCF Based) falls into.


OSTO:VIMAB
51GF Score
Vimab Group AB OSTO:VIMAB
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Vimab Group AB (OSTO:VIMAB) Overvalued in 2026?

Based on GuruFocus' analysis, Vimab Group AB stock appears to be undervalued. The current stock price of kr2.97 is trading 50.6% below its estimated GF Value™ of kr6.01. GuruFocus considers Vimab Group AB to be Possible Value Trap.

Key valuation signals for OSTO:VIMAB:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: kr6.01 vs. price of kr2.97 (50.6% below fair value)
  • GF Score™: 51/100 with 4 warning signs

No single metric tells the full story. See the OSTO:VIMAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vimab Group AB Business Description

Address Malmskillnadsgatan 40A, Stockholm, SWE, 111 57
Vimab Group AB is a Nordic company helping companies with transformation and improvement initiatives. It offers services including Interim management, Executive search.
51GF Score

Get the complete analysis for OSTO:VIMAB

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr2.97
Price
kr6.01
GF Value